Skip to main content
. 2007 Dec 12;46(2):689–699. doi: 10.1128/JCM.01821-07

TABLE 2.

Spoligotypes, nucleotide changes in drug resistance genes and ogt codon 15, and phenotypic drug resistance profiles as determined by drug susceptibility testing of selected clinical strains from Brazila

Strain INH resistance profile Change in katG sequence Change in inhA sequence RIF resistance profile Change in rpoB sequence EMB resistance profile Change in ogt codon 15 sequence Spoligotypeb
1 R ACC15AGC Haarlem3
2 R wt X2
3 R wt LAM6
4 R ACC15AGC Haarlem1
5 R ACC15AGC Haarlem3
6 R ACC15AGC Haarlem3
7 R wt Beijing
8 R wt LAM9
9 R ACC15AGC Haarlem3
10 R ACC15AGC Haarlem3
11 R wt S
12 R ACC15AGC Haarlem3
13 R ACC15AGC Haarlem3
14 R CTG300CCG C(−15)T CAC526GAC wt LAM4
15 R wt C(−15)T TCG531TTG wt T1
16 R wt C(−15)T TCG531TTG wt T1
17 R AGC315ACC wt R TCG531TGG R wt LAM2
18 R AGC315ACC wt R TCG531TTG wt LAM3
19 R wt C(−15)T S wt R wt T1
20 R wt C(−15)T S wt S wt LAM9
21 R AGC315ACC wt R ACC525ACG, CAC526TCC, AAG527CAG S wt LAM9
22 R wt wt S wt S wt LAM4
23 R wt C(−15)T S wt S wt LAM2
24 R AGC315ACC C(−15)T CAC526TCC wt T1
25 R AGC315ACC C(−15)T CAC526TAC wt LAM1
26 R AGC315ACC wt R TCG531TTG ACC15AGC Haarlem1
27 R AGC315ACC C(−15)T R CAC526TAC S wt LAM4
28 R wt wt R GAC516TAC R wt U
29 R AGC315ACC wt R GAC516GTC S wt LAM3/S
30 R AGC315ACC C(−15)T CAC526TAC
31 R AGC315ACC wt R CAC526CTC R
32 R AGC315ACC wt R TCG531TTG R
33 R AGC315ACC wt R TCG531TTG R
34 R wt wt R wt R
35 R AGC299GGC wt R TCG531TTG R
36 R wt wt S wt R
37 R wt wt ATG515ATT, GAC516TAC
38 R wt C(−15)T R TCG531TTG S
39 R wt C(−15)T TCG531TTG
40 R wt C(−15)T TCG531TTG
41 R AGC315ACC wt R GTC176TTC
42 R AGC315ACC wt R GAC516GAG, TCG522TTG S
43 R wt wt R TCG531TTG R
44 R wt C(−15)T R TCG531TTG R
45 R AGC315ACC wt R TCG531TTG S
46 R AGC315ACC wt R CAC526GAC S
47 R AGC315ACC wt S wt R
a

R, resistant; S, susceptible; —, not determined or data not available; wt, wild type.

b

See reference 6.